RhumbLine Advisers’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
102,608
-9,021
| -8% | -$24.2K | ﹤0.01% | 3047 |
|
|
2025
Q1 | $157K | Buy |
111,629
+1,592
| +1% | +$2.25K | ﹤0.01% | 3223 |
|
|
2024
Q4 | $219K | Buy |
110,037
+14,848
| +16% | +$29.5K | ﹤0.01% | 3147 |
|
|
2024
Q3 | $300K | Buy |
95,189
+9,212
| +11% | +$29K | ﹤0.01% | 3024 |
|
|
2024
Q2 | $272K | Buy |
+85,977
| New | +$272K | ﹤0.01% | 3059 |
|